281 related articles for article (PubMed ID: 21750605)
21. Vitreous levels of Lipocalin-2 on patients with primary rhegmatogenous retinal detachment.
Batsos G; Christodoulou E; Vartholomatos G; Galanis P; Stefaniotou M
PLoS One; 2019; 14(12):e0227266. PubMed ID: 31891637
[TBL] [Abstract][Full Text] [Related]
22. [Pathomorphology of membranes appearing in proliferative vitreoretinopathies].
Laudańska-Olszewska I; Omulecki W; Dziegielewski K; Pikulski Z; Omulecka A
Klin Oczna; 2006; 108(1-3):28-31. PubMed ID: 16883935
[TBL] [Abstract][Full Text] [Related]
23. Recognition of vitreoschisis in proliferative diabetic retinopathy. A useful landmark in vitrectomy for diabetic traction retinal detachment.
Schwatz SD; Alexander R; Hiscott P; Gregor ZJ
Ophthalmology; 1996 Feb; 103(2):323-8. PubMed ID: 8594521
[TBL] [Abstract][Full Text] [Related]
24. Effect of Methotrexate on an In Vitro Patient-Derived Model of Proliferative Vitreoretinopathy.
Amarnani D; Machuca-Parra AI; Wong LL; Marko CK; Stefater JA; Stryjewski TP; Eliott D; Arboleda-Velasquez JF; Kim LA
Invest Ophthalmol Vis Sci; 2017 Aug; 58(10):3940-3949. PubMed ID: 28777835
[TBL] [Abstract][Full Text] [Related]
25. Immunocytochemical study of cells in the vitreous of proliferative vitreoretretinopathy.
Liu B; Hui Y; Ma J; Du H
Yan Ke Xue Bao; 1999 Mar; 15(1):13-6. PubMed ID: 12579654
[TBL] [Abstract][Full Text] [Related]
26. [The effect of platelet-derived growth factor on the formation of proliferative vitreoretinopathy].
Liang Y; Li X; Fan J; Zhao M; Jiang Y
Zhonghua Yan Ke Za Zhi; 2002 Mar; 38(3):144-7. PubMed ID: 11955317
[TBL] [Abstract][Full Text] [Related]
27. Activation of neural progenitor cells in human eyes with proliferative vitreoretinopathy.
Johnsen EO; Frøen RC; Albert R; Omdal BK; Sarang Z; Berta A; Nicolaissen B; Petrovski G; Moe MC
Exp Eye Res; 2012 May; 98():28-36. PubMed ID: 22465407
[TBL] [Abstract][Full Text] [Related]
28. Initial clinical experience with an erbium:YAG laser for vitreoretinal surgery.
D'Amico DJ; Brazitikos PD; Marcellino GR; Finn SM; Hobart JL
Am J Ophthalmol; 1996 Apr; 121(4):414-25. PubMed ID: 8604735
[TBL] [Abstract][Full Text] [Related]
29. Comparison of histopathological findings between idiopathic and secondary epiretinal membranes.
Ueki M; Morishita S; Kohmoto R; Fukumoto M; Suzuki H; Sato T; Kobayashi T; Kida T; Oku H; Ikeda T; Shibayama Y
Int Ophthalmol; 2016 Oct; 36(5):713-8. PubMed ID: 26857724
[TBL] [Abstract][Full Text] [Related]
30. Rabbit retinal Müller cells undergo antigenic changes in response to experimentally induced proliferative vitreoretinopathy.
McGillem GS; Dacheux RF
Exp Eye Res; 1999 May; 68(5):617-27. PubMed ID: 10328976
[TBL] [Abstract][Full Text] [Related]
31. Characteristics and vitreoretinal management of retinal detachment in eyes with Boston keratoprosthesis.
Petrou P; Banerjee PJ; Wilkins MR; Singh M; Eastlake K; Limb GA; Charteris DG
Br J Ophthalmol; 2017 May; 101(5):629-633. PubMed ID: 27565989
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive circular RNA profiling of proliferative vitreoretinopathy and its clinical significance.
Yao J; Hu LL; Li XM; Shan K; Zhou RM; Ge HM; Yao MD; Jiang Q; Zhao C; Yan B
Biomed Pharmacother; 2019 Mar; 111():548-554. PubMed ID: 30597308
[TBL] [Abstract][Full Text] [Related]
33. Evidence that neurites in human epiretinal membranes express melanopsin, calretinin, rod opsin and neurofilament protein.
Lesnik Oberstein SY; Lewis GP; Dutra T; Fisher SK
Br J Ophthalmol; 2011 Feb; 95(2):266-72. PubMed ID: 20971788
[TBL] [Abstract][Full Text] [Related]
34. Diabetic patients and retinal proliferation: an evaluation of the role of vascular endothelial growth factor (VEGF).
Nicoletti VG; Nicoletti R; Ferrara N; Meli G; Reibaldi M; Reibaldi A
Exp Clin Endocrinol Diabetes; 2003 Jun; 111(4):209-14. PubMed ID: 12845559
[TBL] [Abstract][Full Text] [Related]
35. TGF-beta1, TGF-beta receptor II and ED-A fibronectin expression in myofibroblast of vitreoretinopathy.
Bochaton-Piallat ML; Kapetanios AD; Donati G; Redard M; Gabbiani G; Pournaras CJ
Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2336-42. PubMed ID: 10892881
[TBL] [Abstract][Full Text] [Related]
36. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases.
Robbins SG; Mixon RN; Wilson DJ; Hart CE; Robertson JE; Westra I; Planck SR; Rosenbaum JT
Invest Ophthalmol Vis Sci; 1994 Sep; 35(10):3649-63. PubMed ID: 8088954
[TBL] [Abstract][Full Text] [Related]
37. Levels of pentosidine in the vitreous of eyes with proliferative diabetic retinopathy, proliferative vitreoretinopathy and retinal detachment.
Tomé CC; De Rojas Silva MV; Rodríguez-García J; Rodríguez-Segade S; Sánchez-Salorio M
Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1272-6. PubMed ID: 15947940
[TBL] [Abstract][Full Text] [Related]
38. Vitreous M2 Macrophage-Derived Microparticles Promote RPE Cell Proliferation and Migration in Traumatic Proliferative Vitreoretinopathy.
Song Y; Liao M; Zhao X; Han H; Dong X; Wang X; Du M; Yan H
Invest Ophthalmol Vis Sci; 2021 Sep; 62(12):26. PubMed ID: 34554178
[TBL] [Abstract][Full Text] [Related]
39. Comparison of Surgically Excised Premacular Membranes in Eyes with Macular Pucker and Proliferative Vitreoretinopathy.
Guenther SR; Schumann RG; Hagenau F; Wolf A; Priglinger SG; Vogt D
Curr Eye Res; 2019 Mar; 44(3):341-349. PubMed ID: 30373411
[TBL] [Abstract][Full Text] [Related]
40. Hyperconvolution of the inner limiting membrane in vitreomaculopathies.
Snead DR; Cullen N; James S; Poulson AV; Morris AH; Lukaris A; Scott JD; Richards AJ; Snead MP
Graefes Arch Clin Exp Ophthalmol; 2004 Oct; 242(10):853-62. PubMed ID: 15480733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
